TrialBlood advances2022

Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.